Financhill
Back

Arcutis Biotherapeutics Vs. Axsome Therapeutics Industry Stock Comparison

Sell
26

ARQT
Arcutis Biotherapeutics

Last Price:
9.37
Seasonality Move:
-16.47%
Sell
35

AXSM
Axsome Therapeutics

Last Price:
89.56
Seasonality Move:
40.46%
Sell
26
Arcutis Biotherapeutics (ARQT) is a Sell

Is Arcutis Biotherapeutics a Buy, Sell or Hold?

  • The current Arcutis Biotherapeutics [ARQT] share price is $9.36. The Score for ARQT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • ARQT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Axsome Therapeutics (AXSM) is a Sell

Is Axsome Therapeutics a Buy, Sell or Hold?

  • The current Axsome Therapeutics [AXSM] share price is $89.64. The Score for AXSM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ARQT Stock Price Chart

What is Arcutis Biotherapeutics's stock price today?

  • The Arcutis Biotherapeutics share price today is $9.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARQT is experiencing buying pressure, which is a positive indicator for future bullish movement.

AXSM Stock Price Chart

What is Axsome Therapeutics's stock price today?

  • The Axsome Therapeutics share price today is $89.64
    The current trend is moderately bearish and AXSM is experiencing slight selling pressure.

ARQT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 41.78 Sell
Chaikin Money Flow: 1499214 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.76 - 10.82) Sell
Bollinger Bands (100): (8.44 - 10.34) Sell

AXSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 47.36 Sell
Chaikin Money Flow: -108941 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (89.1 - 93.64) Sell
Bollinger Bands (100): (76.22 - 89.56) Buy

ARQT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.7 Sell
20-day SMA: 10.23 Sell
50-day SMA: 9.8 Sell
200-day SMA: 8.41 Buy
8-day EMA: 9.62 Sell
20-day EMA: 9.91 Sell
50-day EMA: 9.82 Sell
200-day EMA: 8.99 Buy

AXSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.74 Sell
20-day SMA: 92.06 Sell
50-day SMA: 88.52 Buy
200-day SMA: 81.3 Buy
8-day EMA: 91.03 Sell
20-day EMA: 91.07 Sell
50-day EMA: 88.42 Buy
200-day EMA: 80.96 Buy

Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.

Axsome Therapeutics Earnings Growth & AXSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.99 per share, a decrease this year of $1.26 per share, and an increase next year of $3.97 per share.

Arcutis Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Axsome Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):